"10.1371_journal.pone.0039187","plos one","2012-06-18T00:00:00Z","Yukari C Manabe; Sabine M Hermans; Mohammed Lamorde; Barbara Castelnuovo; C Daniel Mullins; Andreas Kuznik","Infectious Diseases Institute, Makerere University College of Health Sciences, Kampala, Uganda; Division of Infectious Diseases, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland, United States of America; Department of Global Health, Academic Medical Center, University of Amsterdam, Amsterdam Institute for Global Health and Development, Amsterdam, The Netherlands; Department of Pharmacology and Therapeutics, Trinity College Dublin, Dublin, Ireland; University of Maryland, Baltimore, Maryland, United States of America; Pfizer Inc., New York, New York, United States of America","Conceived and designed the experiments: YCM SMH ML BC CDM AK. Performed the experiments: SMH ML AK. Analyzed the data: YCM SMH ML BC CDM AK. Wrote the paper: YCM SMH ML BC CDM AK.","AK is an employee of Pfizer, Inc. and did this work while at IDI as a Pfizer Global Fellow. Dr. Mullins has received consultantâ€™s fees from Bayer Pharmaceuticals Corporation, Bristol-Myers Squibb Company, Eisai Ltd, Novartis, Pfizer, and Sanofi-Aventis; and grant support from Bayer, Novartis, Pfizer, and Sanofi-Aventis. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.","2012","06","Yukari C Manabe","YCM",6,TRUE,6,3,6,6,TRUE,TRUE,FALSE,0,NA,FALSE
